WuXi Biologics News and Activities

WuXi Biologics is owned by HiberCell. HiberCell has a direct presence in 2 countries.

HiberCell has 7 subsidiaries including Genuity Science, STA Pharmaceutical and WuXi AppTec.

They are in:

• Biotechnology88%
• Pharmaceuticals13%

View the org chart displaying its 32 main executives

Most searched biographies at WuXi Biologics

• Chris Chen, Chief Executive Officer
• Yanling Cao, Non-Executive Director
• William Keller, Independent Non-Executive Director

Create your alert
to follow the executive moves at WuXi Biologics.

HiberCell has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by WuXi Biologics

Social media about WuXi Biologics

• WuXi Biologics on Wikipedia, Google News & Yahoo Finance
• WuXi Biologics on LinkedIn, X (Twitter) & YouTube